Maravai officer acquires 5,006 ESPP shares

Maravai LifeSciences Holdings insider Christine Dolan acquired 5,006 shares of Class A common stock through the company’s 2020 Employee Stock Purchase Plan.

Rhea-AI Filing Summary

Maravai LifeSciences Holdings insider Christine Dolan acquired 5,006 shares of Class A common stock through the company’s 2020 Employee Stock Purchase Plan. The shares were acquired at a price of $1.79 per share and are reported as exempt under Rule 16b-3.

Following this transaction, Dolan directly holds 425,318 shares of Maravai Class A common stock. This filing reflects a routine, compensation-related stock purchase under an employee plan rather than an open-market trade.

Insider Trade Summary

Grant/Award: 5,006 shares

Grant/Award 1 txn

Insider Dolan Christine

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	5,006	$1.79	$9K

Holdings After Transaction: Class A Common Stock — 425,318 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 5,006 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Key Figures

Shares acquired: 5,006 shares Acquisition price: $1.79 per share Total holdings after transaction: 425,318 shares

3 metrics

Shares acquired 5,006 shares Class A Common Stock acquired on May 15, 2026

Acquisition price $1.79 per share Price for ESPP acquisition of Class A shares

Total holdings after transaction 425,318 shares Direct ownership of Class A Common Stock following acquisition

Key Terms

Employee Stock Purchase Plan, Rule 16b-3, Class A Common Stock, Form 4

4 terms

Employee Stock Purchase Plan financial

"pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Rule 16b-3 regulatory

"The acquisition of those 5,006 shares ... was exempt pursuant to Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

Class A Common Stock financial

"acquisition of shares of the Issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Maravai (MRVI) report for Christine Dolan?

Maravai reported that insider Christine Dolan acquired 5,006 shares of Class A common stock. The shares were obtained through the company’s 2020 Employee Stock Purchase Plan as a compensation-related acquisition rather than an open-market purchase.

At what price did Christine Dolan acquire Maravai (MRVI) shares?

Christine Dolan acquired 5,006 Maravai Class A common shares at $1.79 per share. This price reflects the transaction value reported under the employee stock purchase plan and was disclosed as an exempt acquisition under Rule 16b-3.

How many Maravai (MRVI) shares does Christine Dolan hold after this transaction?

After the reported transaction, Christine Dolan directly holds 425,318 shares of Maravai Class A common stock. This total includes the 5,006 shares acquired through the 2020 Employee Stock Purchase Plan in the recently reported Form 4 filing.

Was Christine Dolan’s Maravai (MRVI) share acquisition an open-market purchase?

No, the acquisition was not an open-market purchase. The 5,006 shares of Maravai Class A common stock were obtained through the 2020 Employee Stock Purchase Plan and were reported as exempt from Section 16(b) under Rule 16b-3.

What plan was used for Christine Dolan’s recent Maravai (MRVI) stock acquisition?

The shares were acquired pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. This plan allows eligible employees to purchase company stock, and the reported 5,006-share acquisition was disclosed as exempt under Rule 16b-3.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dolan Christine

(Last) (First) (Middle)

C/O MARAVAI LIFESCIENCES HOLDINGS, INC.

10770 WATERIDGE CIRCLE, SUITE 200

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/15/2026		A(1)	V	5,006	A	$1.79	425,318	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 5,006 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Executive Vice President & General Manager, Cygnus Technologies

	/s/ Kurt Oreshack, by power of attorney for Christine Dolan	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)